Campto 40 mg Injection
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Campto 40 mg Injection

Campto 40 mg Injection

Campto 40 mg Injection contains irinotecan hydrochloride trihydrate, a chemotherapy medicine used to treat certain cancers. It is commonly used as part of treatment for colorectal cancer. The medicine is administered as an intravenous infusion by a qualified healthcare professional.

BUY NOW

Category

Campto 40 mg is supplied as a concentrate containing 20 mg/mL of irinotecan hydrochloride trihydrate in a 2 mL vial. Irinotecan works by inhibiting topoisomerase I, an enzyme involved in DNA replication, which helps prevent cancer cells from multiplying. The concentrate must be diluted before administration as an intravenous infusion according to the prescribed chemotherapy regimen. Treatment dose and schedule are determined by the oncology specialist based on the patient’s condition and treatment protocol.

Technical Specification

Specification Details
Active Ingredient Irinotecan Hydrochloride Trihydrate 40 mg
Concentration 20 mg/mL
Dosage Form Concentrate for Solution for Infusion
Vial Volume 2 mL
Therapeutic Class Topoisomerase I Inhibitor
Route of Administration Intravenous Infusion

Product Also Known As

Campto 40 mg Injection, Campto 40 mg/2 mL, Campto Irinotecan 40 mg Injection, Irinotecan 40 mg Injection, Irinotecan Hydrochloride 40 mg Injection, Irinotecan Oncology Injection